SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-15-006435
Filing Date
2015-07-30
Accepted
2015-07-30 12:45:52
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2225470z10-q.htm 10-Q 435620
2 EX-31.1 a2225470zex-31_1.htm EX-31.1 14258
3 EX-32.1 a2225470zex-32_1.htm EX-32.1 7448
10 G556913.JPG g556913.jpg GRAPHIC 12554
  Complete submission text file 0001047469-15-006435.txt   3052541

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20150630.xml EX-101.INS 728873
5 EX-101.SCH nutr-20150630.xsd EX-101.SCH 23107
6 EX-101.CAL nutr-20150630_cal.xml EX-101.CAL 51935
7 EX-101.DEF nutr-20150630_def.xml EX-101.DEF 55753
8 EX-101.LAB nutr-20150630_lab.xml EX-101.LAB 261648
9 EX-101.PRE nutr-20150630_pre.xml EX-101.PRE 163896
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 151015295
SIC: 2833 Medicinal Chemicals & Botanical Products